Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Estrogen helps prevent artery plaque by stopping monocyte capture in blood vessels.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

New drug shows promise for better hair growth in baldness treatment.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.